Login
$FF
$5.80 -$0.03 (0.51%) Close

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Cash and cash equivalents
Accounts receivable, net of allowances for expected credit losses of $36 and $28, respectively
Nonrelated Party
Related Party
Total accounts receivable, net of allowances for expected credit losses of $36 and $28, respectively
Accounts receivable – related parties
Inventory, net
Income tax receivable
Prepaid expenses
Nonrelated Party
Related Party
Total prepaid expenses
Prepaid expenses – related parties
Related Party
Total prepaid expenses – related parties
Marketable securities
Other current assets
Total current assets
Property, plant and equipment, net
Other assets
Total noncurrent assets
Total Assets
Liabilities and Stockholders’ Equity
Accounts payable
Nonrelated Party
Related Party
Total accounts payable
Accounts payable – related parties
Income tax payable
Deferred revenue – current
Dividends payable
Accrued expenses and other current liabilities
Accrued expenses and other current liabilities – related parties
Total current liabilities
Deferred revenue – non-current
Deferred revenue – noncurrent
Dividends payable - noncurrent
Noncurrent deferred income taxes
Other noncurrent liabilities
Total noncurrent liabilities
Total liabilities
Preferred stock, $0.0001 par value, 5,000,000 shares authorized, none issued and outstanding
Common stock, $0.0001 par value, 75,000,000 shares authorized, 43,863,318 and 43,863,507 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Accumulated other comprehensive income
Additional paid in capital
Retained earnings (accumulated deficit)
Total stockholders’ equity
Total Liabilities and Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support